Neuropeptide Mimetics and Antagonists in the Treatment of Inflammatory Disease: Focus on VIP and PACAP

E-ISSN： 1873-4294|6|2|151-163

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.6, Iss.2, 2006-01, pp. : 151-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VIP and PACAP in pain and inflammation

By Said S.I.S.I.

Trends in Pharmacological Sciences, Vol. 21, Iss. 2, 2000-02 ,pp. : 57-57

Elsevier

Access to resources Recommend Favorite

VIP in Inflammatory Bowel Disease: State of the Art

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 4, 2012-12 ,pp. : 316-322

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology of neuropeptide Y receptor antagonists - Focus on cardiovascular functions

By Malmstrom R.E.

European Journal of Pharmacology, Vol. 447, Iss. 1, 2002-06 ,pp. : 11-30

Elsevier

Access to resources Recommend Favorite

VIP and PACAP: very important in pain?

By Dickinson T. Fleetwood-Walker S.M.

Trends in Pharmacological Sciences, Vol. 20, Iss. 8, 1999-08 ,pp. : 324-329

Elsevier

Access to resources Recommend Favorite

Interaction of lipophilic VIP derivatives with recombinant VIP 1 /PACAP and VIP 2 /PACAP receptors

By Gourlet P. Rathe J. De Neef P. Cnudde J. Vandermeers-Piret M.-C. Waelbroeck M. Robberecht P.

European Journal of Pharmacology, Vol. 354, Iss. 1, 1998-07 ,pp. : 105-111

Elsevier

Access to resources Recommend Favorite